L. Nghiemphu

Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma

E. Lander, S. Nelson, G. Getz, 2007, Proceedings of the National Academy of Sciences.

Update and developments in the treatment of glioblastoma multiforme – focus on bevacizumab

T. Cloughesy, P. Mischel, W. Pope, 2010, Pharmacogenomics and personalized medicine.

Tissue microarray analysis for epithelial membrane protein-2 as a novel biomarker for gliomas

T. Cloughesy, L. Liau, A. Lai, 2017, Brain Tumor Pathology.

Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

P. Wen, R. Jain, J. D. de Groot, 2020, Clinical Cancer Research.

Arterial Spin-Labeling Perfusion MRI Stratifies Progression-Free Survival and Correlates with Epidermal Growth Factor Receptor Status in Glioblastoma

T. Cloughesy, N. Salamon, W. Pope, 2015, American Journal of Neuroradiology.

Arterial Spin-Labeling Perfusion MRI Stratifies Progression-Free Survival and Correlates with Epidermal Growth Factor Receptor Status in Glioblastoma

T. Cloughesy, A. Lai, L. Nghiemphu, 2015, American Journal of Neuroradiology.